Translational Genomics Program
Overview
This program supports research that narrows the bridge between basic science and clinical applications with areas of emphasis on identification of genetic biomarkers and qualitative and quantitative endophenotypes, as well as expression analysis, and pharmacogenomics to inform diagnosis, prognosis, drug efficacy and adverse drug reactions.
Areas of Emphasis
- Biomarkers
- Qualitative and quantitative endophenotypes
- Expression analysis
- Pharmacogenomics
Contact
Thomas Lehner, Ph.D., M.P.H
6001 Executive Boulevard, Room 7190, MSC 9643
301-443-9869, tlehner@mail.nih.gov
